Search - tctmd.com

Displaying 441 - 460 of 507

Sort: Relevancy | Date

Presentation THT 2024

Myocardial Recovery at the Level of the Single Myocyte

Presenter: Veli K. Topkara

March 04, 2024

Presentation THT 2024

LV Restoration: The Biology of Biological Reverse Myocardial Remodeling and Recovery

Presenter: Douglas L. Mann

March 04, 2024

Presentation THT 2024

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

Presenter: Emma Birks

March 04, 2024

Presentation THT 2024

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Presenter: Rebecca T. Hahn

March 04, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presenter: Martin B. Leon

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Presenter: James Januzzi

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

Presentation THT 2024

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

Presenter: Benjamin Hibbert

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Opinion Off Script

Passion, Persistence, and Generosity: Remembering Alain Cribier

Martin B. Leon, MD

February 27, 2024

Advertisement

Myocardial Recovery at the Level of the Single Myocyte

LV Restoration: The Biology of Biological Reverse Myocardial Remodeling and Recovery

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Mechanisms of Diuretic Resistance

Contemporary Pharmacological Therapies for Acute Heart Failure

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

TCTMD’s Top 10 Most Popular Stories for February 2024

March 2024 Dispatch for the CV Team

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Passion, Persistence, and Generosity: Remembering Alain Cribier

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content